OneMedNet (NASDAQ:ONMD) CFO Robert Lawrence Golden Sells 2,500 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) CFO Robert Golden sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $6.60, for a total value of $16,500.00. Following the completion of the transaction, the chief financial officer owned 97,291 shares of the company’s stock, valued at $642,120.60. This represents a 2.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Lawrence Golden also recently made the following trade(s):

• On Monday, September 21st, Robert Golden sold 3,000 shares of OneMedNet stock. The stock was sold at an average price of $6.63, for a total value of $19,890.00.
• On Tuesday, September 15th, Robert Golden sold 3,000 shares of OneMedNet stock. The stock was sold at an average price of $6.30, for a total transaction of $18,900.00.

OneMedNet Trading Up 2.3%

OneMedNet stock opened at $4.02 on Wednesday. The company has a 50 day moving average of $6.10 and a 200-day moving average of $7.25. OneMedNet Corporation has a twelve month low of $3.61 and a twelve month high of $32.00.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, OneMedNet has a consensus rating of “Sell”.

About OneMedNet

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.